Health and Fitness Health and Fitness
Mon, July 19, 2010
[ 04:30 AM ] - Market Wire
Oncolytics Biotech(R) Inc. Receives No Objection .. Conduct Phase 3 Trial of REOLYSIN(R) in Head and
[ 04:00 AM ] - Market Wire
Dyax Features Comprehensive Financial Assistance .. nced Product Website for KALBITOR® (ecallantide)
[ 04:00 AM ] - Market Wire
Spectranetics to Hold 2010 Second Quarter Financial Results Conference Call on July 28
[ 03:00 AM ] - Market Wire
BIOLASE Appoints Alex Arrow, MD, CFA, and Norman J. Nemoy, MD, FACS, to Board of Directors
Sun, July 18, 2010
[ 10:26 PM ] - Market Wire
Nycomed's U.S. Patent for Protonix(R) (pantoprazole) Valid
Sat, July 17, 2010
[ 06:57 AM ] - Market Wire
Bull & Lifshitz, LLP Announces Investigation of the Acquisition of NBTY, Inc.
Fri, July 16, 2010
[ 02:00 PM ] - Market Wire
Novartis AG, Altria, Goodyear, Halliburton and Schlumberger
[ 02:00 PM ] - Market Wire
Hospira, Monsanto, Google, Citigroup and Morgan Stanley
[ 01:05 PM ] - Market Wire
Teleflex Announces Conference Call Information for 2010 Second Quarter Earnings
[ 01:05 PM ] - Market Wire
Thermo Fisher Scientific Completes Acquisition of Fermentas
[ 01:00 PM ] - Market Wire
Alliance HealthCare Services, Inc. Announces Comm .. its 8.00% Senior Notes due 2016 for Registered N
[ 12:53 PM ] - Market Wire
The Shuman Law Firm Investigates Gentiva Health Services, Inc.
[ 11:52 AM ] - Market Wire
Aetna Supports Judge Hatchetta?s National Anti-Obesity Campaign
[ 10:00 AM ] - Market Wire
AVI BioPharma Announces Presentations on Exon Ski .. ment of Duchenne Muscular Dystrophy at Internatio
[ 08:30 AM ] - Market Wire
Mannatech, Incorporated Announces Commencement of Stock Option Exchange
[ 07:30 AM ] - Market Wire
Maryland Governor Martin Oa?Malley Leads Ribbon C .. y at Emergenta?s Baltimore Manufacturing Facility
[ 05:45 AM ] - Market Wire
Health Management Associates, Inc. Appoints Alan .. nt of Health Development Operations and Governmen
[ 05:45 AM ] - Market Wire
James Cook University Hospital Introduces Advanced TomoTherapy(R) Radiation Therapy Treatments
[ 05:30 AM ] - Market Wire
Ophthalmic Imaging Systems Supports Final Ruling on ARRA Incentives for EHR Adoption
[ 05:01 AM ] - Market Wire
Molecular Insight Receives Fifth Extension of Waiver Agreement with Bond Holders
[ 04:45 AM ] - Market Wire
AVI BioPharma Discloses New Contract With U.S. Go .. g of up to $291 Million to Advance Development of
[ 04:00 AM ] - Market Wire
Schiff Nutrition International, Inc. Announces Ti .. f Fiscal 2010 Fourth Quarter and Year End Results
[ 03:00 AM ] - Market Wire
Illumina Announces Appointment of Melina Cimler as Vice President, Quality and Regulatory Affairs
Thu, July 15, 2010
[ 10:43 PM ] - Market Wire
Galapagos and University of Bristol enter drug discovery collaboration in chronic pain
[ 07:00 PM ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Investigation of NBTY, Inc.
[ 06:30 PM ] - Market Wire
Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of NBTY, Inc.
[ 04:48 PM ] - Market Wire
Response Genetics Inc. legt Datum fr Jahreshauptv .. und gibt Kandidaten fr den Verwaltungsrat bekannt
[ 02:46 PM ] - Market Wire
Universal Health Services, Inc. Announces Second Quarter 2010 Earnings Release and Conference Call
[ 02:30 PM ] - Market Wire
Elan Corporation, plc Reaches Agreement in Princi .. gation of Past Zonegran Sales and Marketing Activ
[ 02:27 PM ] - Market Wire
AtriCure Announces August Investor Conference Schedule

AtriCure Announces August Investor Conference Schedule


Published on 2010-07-15 14:35:39 - Market Wire
  Print publication without navigation


WEST CHESTER, Ohio--([ BUSINESS WIRE ])--AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems, today announced that it will participate in the following investor conferences during August:

  • The BMO Capital Markets 10th Annual Focus on Healthcare Conference at the Sheraton New York Hotel and Towers. Management is scheduled to present at 11:15 a.m. on Thursday, August 5, 2010.
  • The Canaccord Genuity Growth Conference at the Intercontinental Hotel in Boston. Management is scheduled to present at 9:30 a.m. on Thursday, August 12, 2010.

A live audio webcast and replay of the presentations will be available for 30 days following the presentation at [ www.atricure.com ].

About AtriCure, Inc.
AtriCure, Inc. is a medical device company and a leader in developing, manufacturing and selling innovative cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue. For more information, please visit [ www.atricure.com ].

Contributing Sources